Luke Moore

13.2k total citations · 4 hit papers
142 papers, 6.3k citations indexed

About

Luke Moore is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Luke Moore has authored 142 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Applied Microbiology and Biotechnology, 39 papers in Infectious Diseases and 37 papers in Epidemiology. Recurrent topics in Luke Moore's work include Antibiotic Use and Resistance (55 papers), Antibiotic Resistance in Bacteria (23 papers) and Bacterial Identification and Susceptibility Testing (22 papers). Luke Moore is often cited by papers focused on Antibiotic Use and Resistance (55 papers), Antibiotic Resistance in Bacteria (23 papers) and Bacterial Identification and Susceptibility Testing (22 papers). Luke Moore collaborates with scholars based in United Kingdom, United States and South Africa. Luke Moore's co-authors include Alison Holmes, Timothy M. Rawson, Martin Steinbakk, Philippe J. Guérin, Arnfinn Sundsfjord, Laura J. V. Piddock, Sadie Regmi, Abhilasha Karkey, Mark Gilchrist and Nabeela Mughal and has published in prestigious journals such as The Lancet, PLoS ONE and Circulation Research.

In The Last Decade

Luke Moore

134 papers receiving 6.1k citations

Hit Papers

Understanding the mechanisms and drivers of antimicrobial... 2015 2026 2018 2022 2015 2020 2020 2023 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke Moore United Kingdom 34 2.6k 1.7k 1.4k 1.3k 641 142 6.3k
Eili Klein United States 39 2.3k 0.9× 2.0k 1.2× 1.7k 1.2× 1.9k 1.5× 1.1k 1.7× 190 8.6k
Evelina Tacconelli Italy 37 1.7k 0.7× 2.4k 1.4× 1.6k 1.1× 1.7k 1.3× 946 1.5× 137 9.1k
Derek R. MacFadden Canada 26 1.6k 0.6× 1.1k 0.7× 707 0.5× 1.2k 0.9× 366 0.6× 110 4.0k
C. Suetens Belgium 36 1.4k 0.5× 1.5k 0.9× 757 0.5× 1.5k 1.2× 517 0.8× 78 5.2k
Benedikt Huttner Switzerland 37 2.2k 0.9× 875 0.5× 933 0.6× 1.4k 1.1× 305 0.5× 129 4.4k
Tim Eckmanns Germany 39 859 0.3× 1.8k 1.1× 1.2k 0.8× 1.8k 1.4× 633 1.0× 196 5.4k
Didier Guillemot France 39 1.2k 0.5× 1.3k 0.8× 987 0.7× 2.3k 1.8× 427 0.7× 167 5.0k
Marc Mendelson South Africa 40 1.7k 0.7× 1.1k 0.7× 752 0.5× 1.4k 1.1× 259 0.4× 144 4.7k
John H. Powers United States 33 922 0.4× 943 0.6× 1.1k 0.8× 1.3k 1.0× 599 0.9× 136 5.7k
Hanan H. Balkhy Saudi Arabia 43 863 0.3× 3.6k 2.2× 1.3k 0.9× 1.7k 1.3× 583 0.9× 154 8.0k

Countries citing papers authored by Luke Moore

Since Specialization
Citations

This map shows the geographic impact of Luke Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Moore more than expected).

Fields of papers citing papers by Luke Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Moore. The network helps show where Luke Moore may publish in the future.

Co-authorship network of co-authors of Luke Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Luke Moore. A scholar is included among the top collaborators of Luke Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Moore. Luke Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalil, André C., Aastha Chandak, Luke Moore, et al.. (2024). Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19. Clinical Infectious Diseases. 79(Supplement_4). S160–S166.
2.
Grabein, Béatrice, Francis F. Arhin, George L. Daikos, et al.. (2024). Navigating the Current Treatment Landscape of Metallo-β-Lactamase-Producing Gram-Negative Infections: What are the Limitations?. Infectious Diseases and Therapy. 13(11). 2423–2447. 7 indexed citations
3.
Woolley, Stephen, Aula Abbara, Lucy Lamb, et al.. (2024). Conflict and catastrophe-related severe burn injuries: A challenging setting for antimicrobial decision-making. Journal of Infection. 89(3). 106224–106224. 1 indexed citations
5.
Schmidt, Carl, Katherine de Kleer, N. M. Schneider, et al.. (2023). Io’s Optical Aurorae in Jupiter’s Shadow. The Planetary Science Journal. 4(2). 36–36. 11 indexed citations
7.
Moore, Luke, et al.. (2023). High Entropy Borides Synthesized by the Thermal Reduction of Metal Oxides in a Microwave Plasma. Materials. 16(12). 4475–4475. 4 indexed citations
8.
Hughes, Stephen H., et al.. (2023). Novel use of oral chloramphenicol for treatment-resistantMycoplasma genitalium. Sexually Transmitted Infections. 99(3). sextrans–2022. 3 indexed citations
10.
Moore, Luke, et al.. (2022). Point-of-care testing for tetanus immunity: a systematic review and meta-analysis. Emergency Medicine Journal. 39(10). 771–778. 1 indexed citations
11.
Rawson, Timothy M., et al.. (2022). A practical laboratory method to determine ceftazidime-avibactam-aztreonam synergy in patients with New Delhi metallo-beta-lactamase (NDM)–producing Enterobacterales infection. Journal of Global Antimicrobial Resistance. 29. 558–562. 17 indexed citations
12.
Denny, Sarah, Timothy M. Rawson, Giovanni Satta, et al.. (2021). Bacteraemia variation during the COVID-19 pandemic; a multi-centre UK secondary care ecological analysis. BMC Infectious Diseases. 21(1). 556–556. 21 indexed citations
13.
Prendecki, Maria, Candice Clarke, Sarah Gleeson, et al.. (2020). Detection of SARS-CoV-2 Antibodies in Kidney Transplant Recipients. Journal of the American Society of Nephrology. 31(12). 2753–2756. 25 indexed citations
14.
Davies, Anna, L. Teare, Sian Falder, et al.. (2019). Protocol for the development of a core indicator set for reporting burn wound infection in trials: ICon-B study. BMJ Open. 9(5). e026056–e026056. 4 indexed citations
15.
Gill, Dipender, Beben Benyamin, Luke Moore, et al.. (2019). Associations of genetically determined iron status across the phenome: A mendelian randomization study. PLoS Medicine. 16(6). e1002833–e1002833. 41 indexed citations
16.
Rawson, Timothy M., Luke Moore, Bernard Hernandez, et al.. (2016). Patient engagement with infection management in secondary care: a qualitative investigation of current experiences. BMJ Open. 6(10). e011040–e011040. 19 indexed citations
17.
Rawson, Timothy M., Esmita Charani, Luke Moore, et al.. (2016). Mapping the decision pathways of acute infection management in secondary care among UK medical physicians: a qualitative study. BMC Medicine. 14(1). 208–208. 43 indexed citations
18.
Micallef, Christianne, Monsey McLeod, Enrique Castro‐Sánchez, et al.. (2016). An Evidence-Based Antimicrobial Stewardship Smartphone App for Hospital Outpatients: Survey-based Needs Assessment Among Patients. JMIR mhealth and uhealth. 4(3). e83–e83. 9 indexed citations
19.
Birgand, Gabriel, Luke Moore, C. Bourigault, et al.. (2015). Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost?. Clinical Microbiology and Infection. 22(2). 162.e1–162.e9. 30 indexed citations
20.
Moore, Luke, et al.. (2015). WaterborneElizabethkingia meningosepticain Adult Critical Care1. Emerging infectious diseases. 22(1). 9–17. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026